mRNA therapeutics and Vaccines market Size, Share, Trends by 2035

Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry

Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.


It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.
 A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.
 An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
 Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.
 A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).
 An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.
 An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.
 An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.
 A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.
 An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Routes of Administration
 Intradermal
 Intravenous
 Intranasal
 Others

 Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key companies covered in the report
 Arcturus Therapeutics
 BioNTech and Pfizer
 CureVac
 Gennova
 Moderna
 Walvax


To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/mrna-therape

You may also be interested in the following titles:
Gene Switch Market

Digital Biomanufacturing Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#mrna therapeutics and Vaccines Market #mrnatherapeuticsandvaccinesmarketgrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics

https://sattaking.vip

allegiant baggage policy
https://bookingtrolley.com/blo....gs/allegiant-airline

Manufacturing execution systems market Size, Share, Trends by 2035

Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems

Driven by the ongoing innovation in the healthcare industry, as well as the rise in the demand for automated solutions in order to connect, monitor and control the complex production process, the MES providers market for the healthcare sector is likely to witness positive growth over the coming years. It is worth highlighting that, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volumes of data from various sources, as well as to produce value in the form of insights, predictions and actions.

The financial opportunity within the manufacturing execution system providers in healthcare market has been analyzed across the following segments:

 Type of Deployment
 Cloud
 Corporate Datacenter
 Hybrid
 On Premise

 Type of End User
 Life science / Biotechnology Companies
 Medical Device Providers
 Pharmaceutical Companies
 Others

 Key Geographical Regions
 North America
 Europe
 Asia
 Middle East and North Africa
 Latin America
 Rest of the World

The “Manufacturing Execution System Market, 2022-2035” report the following companies, which we identified to be key players in this domain:
 Andea
 Critical Manufacturing
 Dassault Systèmes
 GE Digital
 Infor
 Körber
 Rockwell Automation

Table of Contents

Background

Executive Summary

Introduction

Market Landscape

Key Insights

Partnerships and Collaborations

Company Competitiveness Analysis

Company Profiles

Value Creation Framework: A Strategic Guide to Address Unmet Need For Manufacturing Execution Systems

Market Forecast

Appendix I: Other Figures

Appendix II: Tabulated Data

Appendix III: List of Companies and Organizations


To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/manufacturin

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#manufacturing execution systems Market #manufacturingexecutionsystemsmarket Size #mes#manufacturingexecutionsystems #manufacturingexecutionsystems

Bacteriophage therapeutics market Size, Share, Trends by 2035

With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.

One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.

The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
 Type of Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders
 Distribution by Route of Administration
 Oral Route
 Rectal Route
 Intravesical Route
 Topical Route

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
 Adaptive Phage Therapeutics
 ContaFect
 Eliava BioPreparations
 Micreos
 NPO Microgen
 Phagelux
 Pherecydes Pharma

Table of Content

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE

5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE

6. COMPANY AND DRUG PROFILES

7. CLINICAL TRIAL ANALYSIS

8. PATENT ANALYSIS

9. PUBLICATION BENCHMARKING ANALYSIS

10. ACADEMIC GRANTS ANALYSIS

11. FUNDING AND INVESTMENT ANALYSIS

12. PARTNERSHIPS AND COLLABORATIONS

13. START-UP HEALTH INDEXING

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/....reports/bacteriophag

You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market

Gene Switch Market


You may also like to learn what our experts are sharing in Roots educational series:
T-cell Immunotherapies: The Future of Modern Cancer Treatments

Monkeypox: Disease Overview, Transmission and Diagnosis


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#bacteriophage therapeutics market #bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy